Score Overview
Explore the 2021 public Archive ranking →
Where ResMed Inc has ranked, year by year
Showing 10 years ranking history by HDB Score.
Reached the top 50 on HDB Score in 9 years, the longest run being 7 in a row — but not in 2021.
- RMD
2006: 3.4% · 2021: 10.5% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 222.10 | — |
1 Year2025-09-26 | $ 267.44 | -16.95% |
5 Years2021-09-28 | $ 253.06 | -12.23% |
10 Years2016-09-28 | $ 57.95 | 283.24% |
20 Years2006-09-28 | $ 16.51 | 13x |
30 Years1996-09-27 | $ 1.02 | 218x |
All Time1995-06-02 | $ 0.55 | 401x |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 | All Time1995-06-02 |
|---|---|---|---|---|---|---|---|
| Price | $ 222.10 | $ 267.44 | $ 253.06 | $ 57.95 | $ 16.51 | $ 1.02 | $ 0.55 |
| Return | — | -16.95% | -12.23% | 283.24% | 13x | 218x | 401x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 5.65B | $ 1.52B | $ 1.46B |
| 2025 | $ 5.14B | $ 1.40B | $ 1.20B |
| 2024 | $ 4.68B | $ 1.02B | $ 238M |
| 2023 | $ 4.22B | $ 897M | $ 227M |
| 2022 | $ 3.57B | $ 779M | $ 273M |
| 2021 | $ 3.19B | $ 474M | $ 295M |
| 2020 | $ 2.95B | $ 621M | $ 463M |
| 2019 | $ 2.60B | $ 404M | $ 147M |
| 2018 | $ 2.34B | $ 315M | $ 188M |
| 2017 | $ 2.06B | $ 342M | $ 821M |
| 2016 | $ 1.83B | $ 352M | $ 731M |
| 2015 | $ 1.67B | $ 352M | $ 717M |
| 2014 | $ 1.55B | $ 345M | $ 905M |
| 2013 | $ 1.51B | $ 307M | $ 876M |
| 2012 | $ 1.36B | $ 254M | $ 809M |
| 2011 | $ 1.24B | $ 226M | $ 735M |
| 2010 | $ 1.09B | $ 190M | $ 488M |
| 2009 | $ 920M | $ 146M | $ 415M |
| 2008 | $ 835M | $ 110M | $ 321M |
| 2007 | $ 716M | $ 66M | $ 277M |
| 2006 | $ 606M | $ 88M | $ 219M |
| 2005 | $ 425M | $ 64M | $ 142M |
| 2004 | $ 339M | $ 57M | $ 140M |
| 2003 | $ 273M | $ 45M | $ 121M |
| 2002 | $ 204M | $ 37M | $ 92M |
| 2001 | $ 155M | $ 11M | $ 102M |
| 2000 | $ 115M | $ 22M | $ 21M |
| 1999 | $ 88M | $ 16M | $ 16M |
| 1998 | $ 66M | $ 10M | $ 15M |
| 1997 | $ 49M | $ 7M | $ 9M |
| 1996 | $ 34M | $ 4M | $ 5M |
| IPO1995 | $ 23M | $ 2M | $ 3M |
ResMed Inc fundamental performance
Between 2021 and 2026, revenue grew from $ 3.19B to $ 5.65B and net income grew from $ 474M to $ 1.52B. Revenue increased in every one of those 5 years; net income in every one.
Across ResMed Inc's full reported history, from 1995 to 2026, revenue grew from $ 23M to $ 5.65B and net income grew from $ 2M to $ 1.52B. Revenue increased in 100% of the years measured; net income in 81%.
ResMed Inc currently holds a 20-year HDB Score of 8.7 out of 10. How the HDB Score is calculated.
Membership
Continue RMD’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
